ArticleTropical medicine & international health : TM & IH2026
Lessons for Immunisation Policy and Practice From the Deadly Measles Resurgence in Bangladesh.
Article in Tropical medicine & international health : TM & IH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bangladesh is experiencing one of the deadliest outbreaks of measles in 2026, with at least 472 suspected child deaths and over 67,079 suspected cases as of 27 May 2026. It has happened primarily following a fall in measles vaccination coverage in 2025, largely due to the cancellation of a planned 2024 Measles-Rubella vaccination Campaign and major political unrest. This editorial, based on available surveillance data, disease transmission modelling and lower vaccination coverage, argues that the 2026 measles outbreak was predictable, preventable and needed prompt action and management. We urge attention to addressing the issues related to structural and programmatic barriers, political and financial gaps in the planning, challenges related to Supplementary Immunisation Activity (SIA) scheduling and recommended-to protect vulnerable high-risk communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.